Kimberly-Clark to buy Kenvue in $48.7 billion deal


Huggies, manufactured by Kimberly-Clark and Band-Aid, manufactured by Kenvue.

Getty Images

Kimberly-Clark announced Monday it’s struck an agreement to buy Kenvue in a deal valued at $48.7 billion that would create a consumer staples giant.

The deal is a combination of cash and stock. Shares of Kenvue surged 20% in premarket trading Monday, while shares of Kimberly-Clark plunged 14%.

The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol. It would include 10 billion-dollar brands, the companies said in a news release. The acquisition would be one of the largest on Wall Street this year.

The transaction is expected to close in the second half of 2026.

Kimberly-Clark Chairman and CEO Mike Hsu said in a statement that the companies share a “commitment to developing science and technology to provide extraordinary care.”

“Over the last several years, Kimberly-Clark has undertaken a significant transformation to pivot our portfolio to higher-growth, higher-margin businesses while rewiring our organization to work smarter and faster,” Hsu said. “We have built the foundation and this transaction is a powerful next step in our journey.”

Kenvue, a portfolio of consumer health brands, spun out of Johnson & Johnson in May 2023. Since then, shares have fallen almost 35% from their initial public offering price. As of Friday’s close, Kenvue traded at about $14 per share for a market cap of roughly $27 billion.

Kenvue Chair Larry Merlo said in a statement that following a comprehensive strategic review, the board is “confident this combination represents the best path forward for our shareholders and all other stakeholders.”

Three Kenvue board members will join the Kimberly-Clark board upon the deal’s closing. Hsu will continue to serve as CEO.

The combined company would generate estimated 2025 annual net revenues of roughly $32 billion and adjusted EBITDA of approximately $7 billion, according to the release.

Kimberly-Clark and Kenvue expect about $1.9 billion in cost synergies from the transaction to be realized in the first three years following the deal’s close.


Related Posts

(OFRM) starts trading on the New York Stock Exchange

Jennifer Garner, co-founder of Once Upon a Farm, center, and Cassandra Curtis, co-founder of of Once Upon a Farm, center right, during the company’s initial public offering (IPO) on the…

Goldman Sachs to tap Anthropic AI model to automate accounting, compliance

Goldman Sachs has been working with the artificial intelligence startup Anthropic to create AI agents to automate a growing number of roles within the bank, the firm’s tech chief told…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cocktail trends 2026: Experience a new story in every sip

  • By admin
  • February 7, 2026
  • 0 views
Cocktail trends 2026: Experience a new story in every sip

Transylvania Open: Emma Raducanu holds her nerve to reach first final since 2021 US Open triumph

  • By admin
  • February 7, 2026
  • 0 views
Transylvania Open: Emma Raducanu holds her nerve to reach first final since 2021 US Open triumph

European Stocks Rise as Novo’s Rebound Outweighs Stellantis Drop

  • By admin
  • February 7, 2026
  • 1 views
European Stocks Rise as Novo’s Rebound Outweighs Stellantis Drop

(OFRM) starts trading on the New York Stock Exchange

  • By admin
  • February 7, 2026
  • 2 views
(OFRM) starts trading on the New York Stock Exchange

LA 2028 blueprint for shooters: 6 medals, personalised plans, world-record mindset

  • By admin
  • February 7, 2026
  • 2 views
LA 2028 blueprint for shooters: 6 medals, personalised plans, world-record mindset

From shovelling snow to Eden in 10 days

  • By admin
  • February 7, 2026
  • 2 views
From shovelling snow to Eden in 10 days